Glomerular mRNAs in human type 1 diabetes: biochemical evidence for microalbuminuria as a manifestation of diabetic nephropathy.
暂无分享,去创建一个
G. Striker | S. Adler | D. Cha | S. Feld | C. Nast | J. Lapage | L. Striker | S. Kang | B. Riser | L. Barba
[1] G. Striker,et al. Glomerular type IV collagen in patients with diabetic nephropathy with and without additional glomerular disease. , 2000, Kidney international.
[2] L. Thal,et al. Blood Levels of Alpha-1-Antichymotrypsin and Risk Factors for Alzheimer’s Disease: Effects of Gender and Apolipoprotein E Genotype , 2000, Dementia and Geriatric Cognitive Disorders.
[3] Gary R. Grotendorst,et al. Connective tissue growth factor mediates transforming growth factor β‐induced collagen synthesis: down‐regulation by cAMP , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[4] A. Risch,et al. Mapping AAC1, AAC2 and AACP, the genes for arylamine N-acetyltransferases, carcinogen metabolising enzymes on human chromosome 8p22, a region frequently deleted in tumours. , 1997, Cytogenetics and cell genetics.
[5] P. Lai,et al. Glomerular transforming growth factor-beta1 mRNA as a marker of glomerulosclerosis-application in renal biopsies. , 1997, Nephron.
[6] H. Abboud,et al. Expression of Transforming Growth Factor-β and Type IV Collagen in Early Streptozotocin-Induced Diabetes , 1997, Diabetes.
[7] C. Esposito,et al. Molecular analysis of glomerular diseases in renal biopsies , 1996, Proceedings of the Association of American Physicians.
[8] G. Viberti. Prognostic significance of albuminuria for the development of nephropathy , 1995, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.
[9] M. Steffes,et al. Glomerular Structure in Nonproteinuric IDDM Patients With Various Levels of Albuminuria , 1994, Diabetes.
[10] M. Razzaque,et al. In situ localization of type III and type IV collagen‐expressing cells in human diabetic nephropathy , 1994, The Journal of pathology.
[11] R. Butkowski,et al. Glomerular distribution of type IV collagen in diabetes by high resolution quantitative immunochemistry. , 1994, Kidney international.
[12] Y. Tomino,et al. ECM Gene Expression and Its Modulation by Insulin in Diabetic Rats , 1992, Diabetes.
[13] D. Woodrow,et al. Diabetic glomerulosclerosis—immunogold ultrastructural studies on the glomerular distribution of type IV collagen and heparan sulphate proteoglycan , 1992, The Journal of pathology.
[14] E. Schleicher,et al. Immunohistochemical localization of extracellular matrix components in human diabetic glomerular lesions. , 1991, The American journal of pathology.
[15] H. Makino,et al. Changes in glomerular extracellular matrices components in diabetic nephropathy. , 1991, The Journal of diabetic complications.
[16] D. Noonan,et al. Altered Steady-State mRNA Levels of Basement Membrane Proteins in Diabetic Mouse Kidneys and Thromboxane Synthase Inhibition , 1990, Diabetes.
[17] R. Bilous,et al. Glomerular lesions and urinary albumin excretion in type I diabetes without overt proteinuria. , 1989, The New England journal of medicine.
[18] C. Mogensen,et al. Predicting diabetic nephropathy in insulin-dependent patients. , 1984, The New England journal of medicine.
[19] A. Michael,et al. Polyantigenic Expansion of Basement Membrane Constituents in Diabetic Nephropathy , 1983, Diabetes.
[20] H. Parving,et al. Early detection of patients at risk of developing diabetic nephropathy. A longitudinal study of urinary albumin excretion. , 1982, Acta endocrinologica.
[21] J. Yee,et al. Regulation of connective tissue growth factor activity in cultured rat mesangial cells and its expression in experimental diabetic glomerulosclerosis. , 2000, Journal of the American Society of Nephrology : JASN.
[22] G. Viberti,et al. Predicting diabetic nephropathy. , 1984, The New England journal of medicine.